Description
MODE OF ACTION:
- Saferida prevents glomerular damage in diabetes and attenuated UACR & STGF-b1 levels in microalbuminuric type 2 diabetic patients.
- Saferida prevents deterioration of microalbuminuria and enhances non-toxic sulfate conjugation of paracetamol, thereby controlling paracetamol poisoning
INDICATIONS
- Diabetic Nephropathy
- Paracetamol Poisoning
- Mucolytic
- Radiocontrast induced nephropathy
Dosage
Mucolytic- TID
Paracetamol poisoning- 140 mg/kg followed by maintenance doses of 7O mg/kg for 4 hr for total of 17 doses
Diabetic nephropathy- 3-4 tab a day
Radio contrast induced nephropathy – 600-1200 mg/day for 2 days
Reviews
There are no reviews yet.